Overview
Matthew Gregory practices practicing medicine in Cambridge, United Kingdom.
His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis (NASH).
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Matthew A. Gregory
Is Matthew A. Gregory a top-rated expert for Non-Alcoholic Fatty Liver Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Matthew A. Gregory is classified as an Experienced expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Matthew A. Gregory participate in research or clinical trials?
Yes. Matthew A. Gregory has published 11 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Matthew A. Gregory's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Non-Alcoholic Fatty Liver DiseaseMr. Gregory isExperienced. Learn about Non-Alcoholic Fatty Liver Disease.
- Nonalcoholic Steatohepatitis (NASH)Mr. Gregory isExperienced. Learn about Nonalcoholic Steatohepatitis (NASH).